|
Status |
Public on Jan 12, 2018 |
Title |
SUM44_WT_repl3 |
Sample type |
SRA |
|
|
Source name |
breast cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
tissue: breast cancer cell line biomaterial provider: ATCC cell line: SUM44 estrogen: Yes esr1 mutation: none
|
Treatment protocol |
LTED cells modeling resistance to an AI were derived from long-term culture in the presence of RPMI1640 medium containing 10% dextran charcoal stripped serum (DCC)
|
Growth protocol |
cultured in phenol red-free RPMI1640 medium supplemented with 10% FBS and 1 nmol/L estradiol (E2)
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using the RNeasy kit (Qiagen) Libraries were created after Ribo-zero rRNA removal kit (Illumina) using NEBNext Ultra Directional RNA (NEB) kit
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Description |
SUM44 WT replicate 3
|
Data processing |
Tophat (v2.1) and Cuffdiff (v2.2.1) using default parameters Genome_build: Human Reference Genome (assembly hg19) Supplementary_files_format_and_content: Cuffdiff output files
|
|
|
Submission date |
Jun 15, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Eugene Schuster |
E-mail(s) |
[email protected]
|
Phone |
+442088082619
|
Organization name |
Institute of Cancer Research
|
Department |
Breast Cancer Research
|
Lab |
Endocrinology
|
Street address |
123 Old Brompton Road
|
City |
London |
ZIP/Postal code |
SW7 3RP |
Country |
United Kingdom |
|
|
Platform ID |
GPL16791 |
Series (2) |
GSE100075 |
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
GSE100076 |
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
|
Relations |
BioSample |
SAMN07246996 |
SRA |
SRX2922248 |